Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate dehydrogenase kinase 1 (PDK1) mRNA is the messenger RNA transcript that encodes the PDK1 enzyme, a key metabolic gatekeeper located in the mitochondria. The encoded protein regulates the pyruvate dehydrogenase complex (PDC) by phosphorylating its E1 alpha subunit, thereby inhibiting the conversion of pyruvate into acetyl-CoA and suppressing mitochondrial oxidative respiration. This mechanism is a central component of the Warburg effect, where cancer cells preferentially utilize glycolysis even in the presence of oxygen to support rapid proliferation. PDK1 mRNA is frequently overexpressed in various malignancies, often under the control of hypoxia-inducible factor 1-alpha (HIF-1α), making it a prime target for therapeutic downregulation. Experimental strategies using siRNAs, shRNAs, or antisense oligonucleotides (ASOs) aim to degrade PDK1 mRNA to restore PDC activity, increase oxidative phosphorylation, and promote apoptosis in tumor cells. Additionally, the PDK1 pathway is a focus of research in metabolic diseases such as diabetes and heart failure, where modulating the glucose-to-oxidative metabolism balance can offer therapeutic benefits.
RNA interference or antisense-mediated degradation of the PDK1 mRNA transcript, which reduces the translation of the PDK1 protein. This reduction leads to the reactivation of the pyruvate dehydrogenase complex, promoting the conversion of pyruvate to acetyl-CoA and shifting cellular metabolism from glycolysis to oxidative phosphorylation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate dehydrogenase kinase 1 mRNA (PDK1 mRNA).